Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
First Japanese Institution to Utilize SOPHiA GENETICS' Myeloid Plus Solution 2022-02-22 20:57
RosVivo Therapeutics, Inc. signed a Material Transfer Agreement (MTA) for first-in-class diabetes treatment with Eli Lilly and Company 2022-02-22 20:52
Gracell Biotechnologies Announces Multiple Advancements of TruUCAR Allogeneic CAR-T Platform 2022-02-22 20:30
InnoCare Announces Dosing of First Patient in Phase II Clinical Trial Using Orelabrutinib for the Treatment of ITP 2022-02-22 17:09
4D IMAGING RADAR LEADER VAYYAR EXPANDS GLOBAL FOOTPRINT WITH NEW JAPAN OFFICE 2022-02-22 17:00
111 to Announce Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results on March 17, 2022 - Conference Call to Follow 2022-02-22 16:38
Nippon Express Obtains GDP Certification for Temperature-controlled Facility at Kansai International Airport 2022-02-22 15:00
Nanoform 4Q and full year 2021 report: accelerating GMP growth 2022-02-22 14:33
Winner Silver Alginate Dressing has Obtained 510K Code in the USA 2022-02-22 10:10
Revotek Receives Clearance from the National Health Commission of China for the World First Clinical Trial for 3D Bioprinted Stem Cell Vascular Grafts 2022-02-21 22:30
HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer 2022-02-21 22:00
Daewoong Pharmaceutical Posts Record Annual Revenue in 2021, with Export Growth of Nabota and New Drug Development 2022-02-21 22:00
Adlai Nortye Announces Publication of Preclinical Research of AN3025 (anti-hTNFR2）in Frontiers in Immunology 2022-02-21 21:00
Harbour BioMed Announces IND Approval for Next-Gen Anti-TSLP Fully Human Monoclonal Antibody 2022-02-21 20:29
CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China 2022-02-21 08:05
VISTA Eye Specialists works with Tzu Chi Malaysia to Help Restore Eyesight with 100 Charity Cataract Surgery 2022-02-21 08:00
Innovent Announces First Patient Dosing of Universal "Modular" CAR-T Cell product IBI345 2022-02-21 08:00
Meihua International Medical Technologies Co., Ltd. Announces Closing of $39.4 Million Initial Public Offering 2022-02-19 05:30
OliPass Announces Commencement of Dosing in Phase 2a Trial for Pain Killer OLP-1002 2022-02-18 23:00
Keymed Bio Joins Hang Seng Family of Indexes 2022-02-18 22:10
1 285 286 287 288 289 896